US6190880B1
Expired / Lapsed
US
⏱️ 0.0 years remaining
Recombinant bone morphogenetic protein heterodimers, compositions and methods of use
Assignee: Genetics Institute LLC
•
Filing: 1995-06-06
•
Granted: 2001-02-20
•
Expires: 2015-06-06
Abstract
Abstract The present invention relates to a methods for producing recombinant heterodimeric BMP proteins useful in the field of treating bone defects, healing bone injury and in wound healing in general. The invention also relates to the recombinant heterodimers and compositions containing them.
Inventors
- 👤 David Israel
- 👤 Neil M. Wolfman
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-24 23:25
CPC Classifications
C; C12; C12N; C12N15/00; C12N15/09; C12N15/11; A; A61; A61L; A61L27/00; A61L27/14; A61L27/22; A61L27/227; A61P; A61P17/00; A61P17/02; A61P19/00; A61P19/08; A61P43/00; C07; C07K; C07K14/00; C07K14/435; C07K14/475; C07K14/51; A61K; A61K38/00
Claims Analysis
Total Claims: 30
Claim 1
Independent Claim
76 words
A method for producing a heterodimeric protein having bone stimulating activity comprising culturing under suitable conditions to produce said protein a selected host cell containing a first DNA sequence encoding a BMP selected from the group consisting of BMP-2 and BMP-4 and a second DNA sequence encoding BMP-5, said sequences each being under the control of a suitable regulatory sequence capable of directing co-expression of said proteins, and isolating said heterodimeric protein from the culture medium.
Claim 2
Independent Claim
76 words
A method for producing a heterodimeric protein having bone stimulating activity comprising culturing under suitable conditions to produce said protein a selected host cell containing a first DNA sequence encoding a BMP selected from the group consisting of BMP-2 and BMP-4 and a second DNA sequence encoding BMP-5, said sequences each being under the control of a suitable regulatory sequence capable of directing co-expression of said proteins, and isolating said heterodimeric protein from the culture medium.
Claim 3
Dependent Claim
36 words
The method according to claim 1 wherein said first DNA is present on a first vector transfected into said host cell and said second DNA is present on a second vector transfected into said host cell.
Claim 4
Dependent Claim
19 words
The method according to claim 1 wherein both said BMPs are integrated into a chromosome of said host cell.
Claim 5
Dependent Claim
15 words
The method according to claim 1 wherein both BMPs are present on a single vector.
Claim 6
Dependent Claim
24 words
The method according to claim 2 wherein more than a single copy of the gene encoding each said BMP is present on each vector.
Claim 7
Dependent Claim
64 words
The method according to claim 1 wherein said host cell is a hybrid cell prepared by culturing two fused selected, stable host cells, each host cell transfected with a DNA sequence encoding said selected first or second BMP, said sequences under the control of a suitable regulatory sequence capable of directing expression of each protein, and isolating said heterodimer protein from the culture medium.
Claim 8
Dependent Claim
14 words
The method according to claim 1 wherein said host cell is a mammalian cell.
Claim 9
Dependent Claim
14 words
The method according to claim 1 wherein said host cell is an insect cell.
Claim 10
Dependent Claim
14 words
The method according to claim 1 wherein said host cell is a yeast cell.
Claim 11
Independent Claim
155 words
A method for producing a heterodimeric protein having bone stimulating activity in a bacterial cell comprising culturing a selected host cell containing a first DNA sequence encoding a BMP selected from the group consisting of BMP-2 and BMP-4 under the control of a suitable regulatory sequence capable of directing expression of the protein under conditions suitable for the formation of a soluble, monomeric protein; isolating said monomeric protein from inclusion bodies and/or said culture medium; culturing a selected host cell containing a second DNA sequence encoding BMP-5 under the control of a suitable regulatory sequence capable of directing expression of the protein or protein fragment under said conditions to form a second soluble, monomeric protein; isolating said monomeric protein from inclusion bodies and/or said culture medium; and mixing said soluble monomeric proteins under conditions permitting the formation of dimeric proteins associated by at least one covalent disulfide bond; isolating from the mixture a heterodimeric protein.
Claim 12
Independent Claim
155 words
A method for producing a heterodimeric protein having bone stimulating activity in a bacterial cell comprising culturing a selected host cell containing a first DNA sequence encoding a BMP selected from the group consisting of BMP-2 and BMP-4 under the control of a suitable regulatory sequence capable of directing expression of the protein under conditions suitable for the formation of a soluble, monomeric protein; isolating said monomeric protein from inclusion bodies and/or said culture medium; culturing a selected host cell containing a second DNA sequence encoding BMP-5 under the control of a suitable regulatory sequence capable of directing expression of the protein or protein fragment under said conditions to form a second soluble, monomeric protein; isolating said monomeric protein from inclusion bodies and/or said culture medium; and mixing said soluble monomeric proteins under conditions permitting the formation of dimeric proteins associated by at least one covalent disulfide bond; isolating from the mixture a heterodimeric protein.
Claim 13
Dependent Claim
13 words
The method according to claim 10 wherein said host cell is E. coli.
Claim 14
Dependent Claim
17 words
The method according to claim 10 wherein said conditions comprise treating said protein with a solubilizing agent.
Claim 15
Dependent Claim
34 words
An isolated recombinant heterodimeric protein having bone stimulating activity comprising a first BMP protein selected from the group consisting of BMP-2 and BMP-4 associated by at least one disulfide bond with a BMP-5 protein.
Claim 16
Dependent Claim
34 words
An isolated recombinant heterodimeric protein having bone stimulating activity comprising a first BMP protein selected from the group consisting of BMP-2 and BMP-4 associated by at least one disulfide bond with a BMP-5 protein.
Claim 17
Dependent Claim
12 words
The protein according to claim 13 wherein said first protein is BMP-2.
Claim 18
Dependent Claim
12 words
The protein according to claim 13 wherein said first protein is BMP-4.
Claim 19
Dependent Claim
58 words
An isolated protein comprising a recombinant heterodimeric protein having bone stimulating activity produced by co-expression in a selected host cell and isolation from the culture medium said protein comprising a subunit of a first BMP selected from the group consisting of BMP-2 and BMP-4, associated by at least one disulfide bond with a second subunit of a BMP-5.
Claim 20
Dependent Claim
58 words
An isolated protein comprising a recombinant heterodimeric protein having bone stimulating activity produced by co-expression in a selected host cell and isolation from the culture medium said protein comprising a subunit of a first BMP selected from the group consisting of BMP-2 and BMP-4, associated by at least one disulfide bond with a second subunit of a BMP-5.
Claim 21
Dependent Claim
60 words
A cell line comprising a nucleotide sequence encoding a first BMP selected from the group consisting of BMP-2 and BMP-4 under control of a suitable expression regulatory system and a nucleotide sequence encoding a BMP-5 under control of a suitable expression regulatory system, said regulatory systems capable of directing the co-expression of said BMPs and the formation of heterodimeric protein.
Claim 22
Dependent Claim
60 words
A cell line comprising a nucleotide sequence encoding a first BMP selected from the group consisting of BMP-2 and BMP-4 under control of a suitable expression regulatory system and a nucleotide sequence encoding a BMP-5 under control of a suitable expression regulatory system, said regulatory systems capable of directing the co-expression of said BMPs and the formation of heterodimeric protein.
Claim 23
Dependent Claim
21 words
The cell line according to claim 17 wherein said nucleotide sequences encoding BMP proteins are present in a single DNA molecule.
Claim 24
Dependent Claim
37 words
The cell line according to claim 17 wherein said nucleotide sequence encoding said first BMP is present on a first DNA molecule and said nucleotide sequence encoding said second BMP is present on a second DNA molecule.
Claim 25
Dependent Claim
38 words
The cell line according to claim 18 wherein said single DNA molecule comprises a first transcription unit containing a nucleic acid encoding said first BMP and a second transcription unit containing a nucleic acid encoding said second BMP.
Claim 26
Dependent Claim
39 words
The cell line according to claim 18 wherein said single DNA molecule comprises a single transcription unit containing multiple copies of said nucleic acid encoding said first BMP and multiple copies of said nucleic acid encoding said second BMP.
Claim 27
Dependent Claim
44 words
A DNA molecule comprising a sequence encoding a first BMP selected from the group consisting of BMP-2 and BMP4 and a sequence encoding a BMP-5 said sequences under the control of at least one suitable regulatory sequence capable of directing co-expression of each BMP.
Claim 28
Dependent Claim
44 words
A DNA molecule comprising a sequence encoding a first BMP selected from the group consisting of BMP-2 and BMP4 and a sequence encoding a BMP-5 said sequences under the control of at least one suitable regulatory sequence capable of directing co-expression of each BMP.
Claim 29
Dependent Claim
32 words
The molecule according to claim 22 comprising a first transcription unit containing a nucleic acid encoding said first BMP and said second transcription unit containing a nucleic acid encoding said second BMP.
Claim 30
Dependent Claim
33 words
The molecule according to claim 22 comprising a single transcription unit containing multiple copies of said nucleic acid encoding said first BMP and multiple copies of said nucleic acid encoding said second BMP.
References Cited (Backward Citations)
US4789732A
Cited
US4294753A
Cited
US4761471A
Cited
US4455256A
Cited
US4434094A
Cited
US4908204A
Cited
US4992274A
Cited
US4804744A
Cited
US4608199A
Cited
US4774322A
Cited
US4774228A
Cited
US4810691A
Cited
US4843063A
Cited
US4627982A
Cited
US4769328A
Cited
US5187263A
Cited
US4563350A
Cited
US4886747A
Cited
US4681763A
Cited
US4798885A
Cited
US4737578A
Cited
US5166058A
Cited
US5187076A
Cited
US5141905A
Cited
US5106748A
Cited
EP0336760A2
Cited
WO1989010409A1
Cited
US5266683A
Cited
US5258494A
Cited
US4968590A
Cited
WO1989009788A2
Cited
WO1989009787A2
Cited
US5108753A
Cited
US5011691A
Cited
US5106626A
Cited
US5508263A
Cited
US5411941A
Cited
US5284756A
Cited
WO1990003733A1
Cited
WO1990011366A1
Cited
CA2017466A1
Cited
US5399346A
Cited
EP0409472A1
Cited
WO1991002744A1
Cited
EP0416578A2
Cited
WO1991005802A1
Cited
EP0433225A1
Cited
US5650494A
Cited
WO1991018098A1
Cited
WO1991018047A2
Cited
US5208219A
Cited
WO1993000049A1
Cited
EP0626451A2
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 2004-02-20 | 2004-08-21 | 2005-02-20 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2008-02-20 | 2008-08-21 | 2009-02-20 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2012-02-20 | 2012-08-21 | 2013-02-20 | $7700.00 | Window Closed / Lapsed |